###begin article-title 0
Long-Range Enhancer Associated with Chromatin Looping Allows AP-1 Regulation of the Peptidylarginine Deiminase 3 Gene in Differentiated Keratinocyte
###end article-title 0
###begin p 1
Conceived and designed the experiments: SC. Performed the experiments: SC VA. Analyzed the data: SC. Contributed reagents/materials/analysis tools: SC McM SY SD HD MC HT GS. Wrote the paper: SC. Participated in manuscript preparation: MS.
###end p 1
###begin p 2
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 571 575 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 883 887 883 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1193 1197 1193 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1344 1348 1344 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1632 1636 1632 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1700 1705 <span type="species:ncbi:9606">human</span>
Transcription control at a distance is a critical mechanism, particularly for contiguous genes. The peptidylarginine deiminases (PADs) catalyse the conversion of protein-bound arginine into citrulline (deimination), a critical reaction in the pathophysiology of multiple sclerosis, Alzheimer's disease and rheumatoid arthritis, and in the metabolism of the major epidermal barrier protein filaggrin, a strong predisposing factor for atopic dermatitis. PADs are encoded by 5 clustered PADI genes (1p35-6). Unclear are the mechanisms controlling the expression of the gene PADI3 encoding the PAD3 isoform, a strong candidate for the deimination of filaggrin in the terminally differentiating epidermal keratinocyte. We describe the first PAD Intergenic Enhancer (PIE), an evolutionary conserved non coding segment located 86-kb from the PADI3 promoter. PIE is a strong enhancer of the PADI3 promoter in Ca2+-differentiated epidermal keratinocytes, and requires bound AP-1 factors, namely c-Jun and c-Fos. As compared to proliferative keratinocytes, calcium stimulation specifically associates with increased local DNase I hypersensitivity around PIE, and increased physical proximity of PIE and PADI3 as assessed by Chromosome Conformation Capture. The specific AP-1 inhibitor nordihydroguaiaretic acid suppresses the calcium-induced increase of PADI3 mRNA levels in keratinocytes. Our findings pave the way to the exploration of deimination control during tumorigenesis and wound healing, two conditions for which AP-1 factors are critical, and disclose that long-range transcription control has a role in the regulation of the gene PADI3. Since invalidation of distant regulators causes a variety of human diseases, PIE results to be a plausible candidate in association studies on deimination-related disorders or atopic disease.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 260 263 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-The1">[1]</xref>
###xml 433 436 433 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Kleinjan1">[2]</xref>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 555 558 555 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Chavanas1">[3]</xref>
###xml 703 706 703 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Liu1">[4]</xref>
###xml 791 794 791 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Cuthbert1">[5]</xref>
###xml 796 799 796 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Wang1">[6]</xref>
###xml 933 936 933 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Chavanas2">[7]</xref>
###xml 1470 1473 1470 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Senshu1">[8]</xref>
###xml 1658 1661 1658 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Senshu1">[8]</xref>
###xml 1807 1810 1807 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Rawlings1">[9]</xref>
###xml 2103 2107 2103 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Palmer1">[10]</xref>
###xml 2392 2396 2392 2396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 2409 2413 2409 2413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 2582 2586 2582 2586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Nachat1">[11]</xref>
###xml 2660 2668 2660 2668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2668 2672 2668 2672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Mechin1">[12]</xref>
###xml 2762 2769 2762 2769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2871 2875 2871 2875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 2903 2907 2903 2907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 3057 3065 3057 3065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 3127 3131 3127 3131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dong1">[13]</xref>
###xml 3312 3316 3312 3316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Ge1">[14]</xref>
###xml 3317 3321 3317 3321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Zhao1">[17]</xref>
###xml 3446 3450 3442 3446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Romano1">[18]</xref>
###xml 3594 3598 3583 3587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Lok1">[19]</xref>
###xml 3600 3604 3589 3593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Magan1">[20]</xref>
###xml 3617 3621 3606 3610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 3651 3655 3640 3644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dong1">[13]</xref>
###xml 3426 3431 <span type="species:ncbi:10090">mouse</span>
The characterization of the genomic elements which govern the spatial and temporal tuning of gene transcription is a key issue in genomic biology, providing with a better understanding of the cell regulatory networks and the functional landscape of the genome [1]. Notably, transcription control at a distance is a critical mechanism, providing with cell-type specificity of transcription or coordinate expression of clustered genes [2]. The 5 genes (PADI) for the peptidylarginine deiminases (PADs) are clustered on chromosome 1p35-36 (Genbank AJ549502) [3]. PADs catalyse the conversion of protein-bound arginine into citrulline (deimination). Deimination associates with or is a signal for apoptosis [4], and antagonizes histone arginine methylation contributing to transcription control [5], [6]. More, PADs are though to be key factors in the pathophysiology of multiple sclerosis, Alzheimer's disease, and rheumatoid arthritis [7], and in the metabolism of the major epidermal barrier protein filaggrin. Filaggrin (Unigene Hs.654510) is only expressed in the most differentiated keratinocytes of the epidermis within the so-called granular layer. Filaggrin associates with keratin intermediate filaments and facilitates the formation of the intracellular fibrous matrix during the transition from keratinocytes to corneocytes, which constitutes the cornified layer of the epidermis. Filaggrin is extensively deiminated at multiple residues in the early corneocyte [8]. Because of the lower affinity of deiminated filaggrin for keratins, it was proposed that filaggrin deimination facilitates its dissociation from the matrix and subsequent proteolysis [8]. Proteolysis of the deiminated filaggrin yields to a heterogeneous pool of aminoacids which contributes to the Natural Moisturizing Factor (NMF) [9]. The critical role of filaggrin in epidermis homeostasis and barrier function has been evidenced by the recent disclosure that loss-of-function mutations in the filaggrin gene underlie ichthyosis vulgaris (OMIM #146700) and are strong predisposing factors for atopic dermatitis (OMIM %603165)[10]. Abnormal filaggrin deimination should result in altered function and/or turn-over; with possible deleterious consequences in epidermis barrier function which might contribute to the outcome of atopy or other disorders. PAD3 is a strong candidate for filaggrin deimination. Among the PADI genes, only PADI3 shows specific expression in the granular layer and co-localization with filaggrin in the cytosol of granular keratinocytes and in the matrix of the lower corneocytes [11]. The enzymatic properties of PAD3 and its ability to deiminate filaggrin in vitro[12] further support the assumption that PAD3 is the best candidate for filaggrin deimination in vivo. In the search for new regulators of filaggrin deimination, we investigated the control of the genes PADI. We have reported that the PADI3 minimal promoter region showed a significant, albeit moderate, increase in activity (1.5-fold) in differentiated versus proliferative keratinocytes in vitro, and required the bound transcription factors NF-Y and Sp1/3 [13]. However, such co-operation is not specific to differentiated keratinocytes since NF-Y and Sp1 govern the transcription of a variety of genes in epithelial or non epithelial cells [14]-[17], as that of the DeltaNp63 isoform of p63, a homolog of the p53 tumour suppressor gene, in proliferative mouse keratinocytes [18]. In the cervical carcinoma HeLa cells, NF-Y and Sp1 enhanced the levels of transcription of the topoisomerase II alpha and beta gene promoters [19], [20] whereas the PADI3 gene promoter is not active [13].
###end p 4
###begin p 5
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 153 156 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Chavanas1">[3]</xref>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
By a comparative genomic approach, we have identified between PADI2 and PADI1 an 8-kb region (IG1) which clusters 19 conserved non coding segments (CNS) [3]. We here disclose that IG1 contains a calcium responsive enhancer which dramatically triggers the activity of the PADI3 gene promoter located 86-kb from it upon epidermal keratinocyte differentiation, and links PADI3 expression to AP-1 transcription factors through chromatin opening and looping.
###end p 5
###begin title 6
Methods
###end title 6
###begin title 7
Cell culture
###end title 7
###begin p 8
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 96 101 <span type="species:ncbi:9606">Human</span>
###xml 382 388 <span type="species:ncbi:9913">bovine</span>
###xml 589 594 <span type="species:ncbi:9606">Human</span>
###xml 674 680 <span type="species:ncbi:9913">bovine</span>
All human samples were obtained after informed consent according to Helsinki principles. Normal Human Epidermal Keratinocytes (NHEKs) isolated from healthy foreskin and the A431 and HaCaT lines (a gift from N. Fusenig, German Cancer Research Center, Heidelberg, Germany) were cultured in a serum-free growth medium (KGM2, Promocell, Heidelberg, Germany) in the presence of 13 mg/ml bovine pituitary extract, 0.125 ng/ml Epidermal Growth Factor, 5 microg/ml insulin, 0.33 microg/ml hydrocortisone, 10 microg/ml transferrin, 0.39 microg/ml epinephrin, and with either 0.2 mM or 1.5 mM Ca2+. Human dermal fibroblasts and HeLa cells were maintained in DMEM with 10% (v/v) fetal bovine serum (Invitrogen, Carlsbad, CA).
###end p 8
###begin title 9
Genomic segments and plasmids
###end title 9
###begin p 10
###xml 162 170 162 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003408.s001">Table S1</xref>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dong1">[13]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dong2">[21]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dong4">[23]</xref>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dpn</italic>
All sequences coordinates refer to a previously deposited sequence (Genbank accession number AJ549502). The primers used in this work are listed in supplementary Table S1. The promoter regions of the genes PADI1-4 comprise the proximal promoters published elsewhere [13], [21]-[23]. Genomic fragments were generated by PCR and subcloned into the pGL3 vector (Promega, Madison, WI). Site-directed mutagenesis was performed using the Vent DNA polymerase and DpnI (New England Biolabs, Ipswich, MA). All constructs were checked by sequence analysis. Dominant-negative plasmids were generous gifts from Melanie Cobb (ERK1-2 mutants), Michael Karin (h-ras, h-raf constructs), and Michael Birrer (TAM67 c-Jun mutant). The plasmid pAP1-luc (BD Bioscience, Mountain View, CA) was kindly provided by Franck Verrechia.
###end p 10
###begin title 11
Transient transfections and luciferase assays
###end title 11
###begin p 12
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Actively proliferating NHEKs were seeded at a density of 25 000 cells/cm2 24 hours before they were transfected by 1 microg total DNA using the TransFast reagent (Promega). The plasmid pCR2.1 (Invitrogen) was used to adjust for the mass of the input DNA when necessary. The plasmid pRL-TK (Promega), used to correct for transfection efficiency, was used at a 1/100 mass ratio versus the pGL3 plasmids. After transfection, the NHEKs were incubated 72 hours in the presence of either 0.2 mM or 1.5 mM calcium before lysis and dual luciferase assay (Promega). All assays were done in triplicate wells, and the experiments were repeated at least two times. Statistical analysis was performed using the StatEL software (Adscience, Paris, France).
###end p 12
###begin title 13
Real time quantitative (Q-)PCR analysis
###end title 13
###begin p 14
All Q-PCRs were based on a SyBr-green based PCR mixture (MP Biomedicals, Solon, OH) and an ABI7300 system (Applied Biosystems, Foster City, CA). All primers pairs were designed using the Primer3 online software () and characterized by real-time amplification of a series of dilution of naked genomic DNA to determine linearity range and primer efficiency. All Q-PCR amplifications were done in triplicate, and the experiments were performed at least twice.
###end p 14
###begin title 15
DNase I hypersensitivity assay
###end title 15
###begin p 16
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-McArthur1">[24]</xref>
###xml 141 149 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003408.s001">Table S1</xref>
We queried the DNase I hypersensitivity of genomic segments as devised elsewhere [24], using oligonucleotides probes listed in supplementary Table S1.
###end p 16
###begin title 17
Electrophoretic Mobility Shift Assay (EMSA)
###end title 17
###begin p 18
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dignam1">[25]</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Virolle1">[26]</xref>
###xml 372 373 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1457 1465 1439 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003408.s001">Table S1</xref>
###xml 469 475 <span type="species:ncbi:9913">bovine</span>
Nuclear proteins were extracted as devised elsewhere [25], and protein amounts were quantified using a Bradford assay (Amresco, Solon, OH). EMSA was performed as reported elsewhere [26]. Briefly, 5 microg of whole cell extract from differentiating NHEKs was incubated in a binding buffer containing 10 mM Hepes, pH 7.8, 50 mM KCl, 2 mM dithiothreitol, 1 mM EDTA, 5 mM MgCl2, 10% glycerol, 3 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 2 mg/ml poly(dI-dC), and 2 mg/ml bovine serum albumin in a total volume of 20 microl at 25 degreesC for 20 min in the presence of 20 fmol of biotin-end-labeled double-strand oligonucleotide probe. DNA-protein complexes were resolved by electrophoresis on 4-6% polyacrylamide gels in 0.5xTBE buffer (50 mM Tris, 45 mM Boric Acid, and 0.5 mM EDTA). Five or 10 microg of antisera against c-Jun (BD, Franklin Lakes, NJ), JunB, JunD, c-Fos, FosB, Fra1 and Fra2 (Santa Cruz Biotechnologies, Santa Cruz, CA) were used in supershift assays. Nucleoprotein complexes were revealed by the Light Shift chemoluminescent assay kit (Pierce, Rockford, IL). Oligonucleotide probes were designed on the basis of the sequence of the centromeric and telomeric AP-1 sites of PIE. Competitors were unlabelled oligonucleotides with the identical sequence (wild-type competitor), or unlabelled oligonucleotides in which the AP-1 consensus sites were mutated (mutated competitor). All probe and competitor sequences are detailed in supplementary Table S1.
###end p 18
###begin title 19
Chromatin ImmunoPrecipitation (ChIP) assay
###end title 19
###begin p 20
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Soutoglou1">[27]</xref>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
ChIP was carried out as published elsewhere [27] using 20x106 NHEKs per experiment. Twenty-five microg of pre-cleared chromatin were immunoprecipitated with 5 microg of the same antibodies that described above, or 5 microg of a monoclonal antibody against the HA epitope (Millipore, Billerica, MA). One tenth of the immunoprecipitated DNA samples and 5 ng input DNA samples were submitted to Q-PCR.
###end p 20
###begin title 21
Chromosome Conformation Capture (3C)
###end title 21
###begin p 22
###xml 63 77 63 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003408.s002">Information S1</xref>
Detailed protocol for 3C in NHEKs is provided as Supplementary Information S1.
###end p 22
###begin p 23
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Tolhuis1">[28]</xref>
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamH</italic>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamH</italic>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamH</italic>
###xml 711 715 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 946 950 946 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 984 988 984 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1027 1031 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1381 1385 1381 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamH</italic>
###xml 1387 1390 1387 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 1418 1422 1418 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Briefly, the 3C assay was performed as described previously [28] using BglII and BamHI for enzymatic digestion of chromatin, and primers designed towards the BamHI restriction sites. A sonication step was found to be necessary after formaldehyde cross-linking of NHEKs for efficient cell lysis and nuclei release, as verified by microscopic examination, but had no detectable effect on chromatin size, as checked by agarose gel electrophoresis. Agarose gel electrophoresis of a purified aliquot of the chromatin restricted by BglII and BamHI showed no detectable difference in digestion efficiency of samples from unstimulated or calcium-stimulated keratinocytes. Quantitative amplification of a segment of the PADI3 gene promoter was used for data normalization. For controls, we used the Bacterial Artificial Chromosome (BAC, AL590644) which contains a 165-kb insert spanning the whole region from the intergenic sequence telomeric to the gene PADI2 to the first intron of the gene PADI4, thereby including IG1 and the genes PADI1 and 3. The BAC clone was used to generate the control for random association events: 1.5 ng of the BAC preparation, restricted and ligated as the nuclei samples, was used as a template in control amplifications. Primer pairs efficiency values were determined from amplifications of a series of dilutions of a control template in which all possible BamHI/BglII ligation products of the PADI gene locus should be equally represented, generated from 30 microg of the BAC preparation, restricted and ligated at a high concentration (300 ng/microl).
###end p 23
###begin title 24
RNA analysis
###end title 24
###begin p 25
###xml 269 277 265 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;Ct</sup>
###xml 285 289 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Livak1">[29]</xref>
###xml 458 462 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Livak1">[29]</xref>
NHEKs were treated for 16 h by 20 microM NDGA (Sigma) in 0.1% DMSO (Sigma), or by 0.1% DMSO. Total RNAs purified using the RNeasy Protect kit (Qiagen) were used as a template for Im-PromII reverse transcriptase (Promega). Q-PCR analysis was performed according to the 2-DeltaCt method [29], using beta2 microglobulin as the reference, PAD1-3 and involucrin as the targets, and untreated NHEKs as the calibrator. Standard deviation were calculated as advised [29] using the methods of standard propagation of error. Actual inhibition of the AP-1 activation system by NDGA was also checked by transfection experiments using the plasmid pAP1-luc.
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Boyce1">[30]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Eckert1">[31]</xref>
###xml 607 611 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Galliano1">[32]</xref>
###xml 950 954 946 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1042 1046 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1237 1244 1233 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g001">Fig. 1A</xref>
###xml 1325 1329 1321 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1578 1582 1574 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1881 1889 1877 1885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1913 1920 1909 1916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g001">Fig. 1B</xref>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 1597 1601 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Normal human epidermal keratinocytes (NHEKs) grown in vitro in the presence of 0.2 mM calcium are actively proliferating. Upon exposure to 1.5 mM calcium, they undergo a differentiation program which closely resembles that of the epidermis; this well documented system recapitulates the natural epidermal calcium gradient [30], [31]. Consistently, in our hands, quantitative RT-PCR and/or western blot analyses show increased mRNA and/or protein levels of markers of the keratinocyte differentiation such as loricrin, involucrin, and the alpha-macroglobulin like inhibitor of protease A2ML1 (not shown, and [32]). The 19 CNS within IG1 are candidates for a role in transcription regulation because inter-species conservation of DNA segments is often predictive of a biological role. We designed a screening strategy based on transfection in NHEKs cultured in both conditions of luciferase reporter plasmids containing the promoter region of the gene PADI3, flanked by each of the 19 CNS. We observed a significantly increased activity of the PADI3 promoter region in the presence of the CNS2 (63 bp, nt 109097-109159). The effect was higher in calcium-stimulated (10-fold induction) as compared to unstimulated cells (6-fold induction) (Fig. 1A). None of the 18 other CNS showed significant and reproductible effect upon the PADI3 gene promoter activity. The activity of the CNS2 did not depend on its orientation (data not shown). This activity was not donor dependent, since it was observed in NHEKs from 4 unrelated individuals. We observed a moderate enhancer effect on the PADI2 gene and the SV40 virus promoter regions in the presence of 1.5 mM calcium. We next queried wether such enhancer activity could be detected in keratinocyte lines. Unexpectedly, the activity of the CNS2 could not be detected in HaCaT immortalized keratinocyte though they are able to differentiate in vitro upon calcium exposure (Fig. 1B). We assume that the genetic alterations present in the HaCaT lineage (one single copy of chromosome 3p, 4p, and 9p and an additional copy of 9q at least) impair the cell responsiveness to CNS2 directly or not. However, the underlying mechanism remains undetermined, given the complexity of genetic alterations and accumulating changes upon passaging in such immortalized cells.
###end p 27
###begin title 28
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Identification of a strong transcriptional enhancer of the gene PADI3 in differentiated keratinocytes.
###end title 28
###begin p 29
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1219 1222 1219 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Chavanas1">[3]</xref>
###xml 1423 1427 1423 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 673 678 <span type="species:ncbi:9606">human</span>
###xml 741 747 <span type="species:ncbi:10090">murine</span>
###xml 1236 1241 <span type="species:ncbi:10090">mouse</span>
###xml 1246 1251 <span type="species:ncbi:9606">human</span>
###xml 1328 1333 <span type="species:ncbi:10090">mouse</span>
###xml 1338 1343 <span type="species:ncbi:9606">human</span>
A) The CNS2 comprises an enhancer of PADI3 gene promoter activity in differentiating NHEKs. NHEKs were transfected with luciferase reporter constructs containing the indicated promoter segment with or without the CNS2 which overlaps PIE, in the presence of 0.2 or 1.5 mM calcium. Values are expressed in Relative Luciferase Units (RLU), as means+/-SEM for at least 3 independent experiments, each performed in triplicate wells.*, p<0.05. B) The CNS2 does not show any detectable enhancer activity either in A431 skin squamous cell carcinoma keratinocytes (top left), in HeLa cervix adenocarcinoma cells (top right), in immortalized HaCaT (bottom left) keratinocytes, or in human primary dermal fibroblasts (bottom right), or 3T3 transformed murine fibroblasts (not shown). C) Schematic representation of the PADI gene locus showing CNS2/PIE (asterisk), IG1 (open box) and the genes PADI1-3 (open boxes with arrows indicating the orientation of transcription). The coordinates in AJ549502 are shown in kb or bp. The telomeric (tel) and centromeric (cen) ends of the locus are shown. The 19 CNSs within IG1 are depicted by vertical bars of lenght depending upon their level of interspecies conservation (for details, see [3]). The entire mouse and human sequences of CNS2/PIE are shown. Underlined are the conserved bases between mouse and human. The centromeric end of the locus (approximatively 100 kb) including the genes PADI4 and 6 is not shown due to size limitation.
###end p 29
###begin p 30
###xml 153 161 153 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 163 170 163 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g001">Fig. 1B</xref>
###xml 234 241 234 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g001">Fig. 1B</xref>
###xml 208 213 <span type="species:ncbi:9606">human</span>
###xml 264 270 <span type="species:ncbi:10090">murine</span>
No effect of CNS2 was observed in skin squamous cell carcinoma keratinocytes A431 and cervix adenocarcinoma HeLa cells which are unable to differentiate in vitro (Fig. 1B). Neither was it detected in primary human dermal fibroblasts (Fig. 1B), nor 3T3 transformed murine fibroblasts (not shown). These results suggested sensitivity to cell type and status.
###end p 30
###begin p 31
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-McArthur1">[24]</xref>
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Layon1">[33]</xref>
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Teix1">[34]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Boyle1">[35]</xref>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Eguchi1">[36]</xref>
###xml 613 616 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBE</italic>
###xml 893 899 887 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g002">Fig. 2</xref>
###xml 1049 1055 1043 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g002">Fig. 2</xref>
###xml 1258 1264 1252 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g002">Fig. 2</xref>
###xml 1574 1578 1568 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Because active enhancers are known to be located in open chromatin regions and thereby show DNase I hypersensitivity, we used a real-time PCR-based approach to assess the integrity of the CNS2 in DNase I treated nuclei prepared from NHEKs [24]. This method had been reported efficient to query the nuclease sensitivity of candidate segments [33], [34] or to build comprehensive maps of open chromatin sites at the genomic or chromosomic levels [35], [36]. We normalized the number of intact remaining copies of CNS2 or of other probes to that of a segment of the promoter region of the fetal epsilon-globin gene (HBE1) which is not transcribed in NHEKs. No significant DNase I hypersensitivity of the CNS2 was detected in proliferating NHEKs, in which a fragment spanning the promoter of the keratin 5 gene, a strongly expressed marker of proliferative keratinocytes, showed hypersensitivity (Fig. 2). In contrast, in calcium-stimulated keratinocytes, increasing amounts of DNase I associated with a dramatic loss of amplifiable copies of the CNS2 (Fig. 2), supporting its role as an enhancer prone to bind transcription activators upon keratinocyte differentiation. Two segments located at the centromeric ends of IG1 showed no hypersensitivity to DNase I (Fig. 2), suggesting that the increased sensitivity to DNAse I we observed was due to local alteration in chromatin accessibility in the close or distant vicinity of the CNS2, and not to a chromatin opening event at the chromosome scale. We concluded that the CNS2 overlaps a strong calcium-dependent enhancer of the PADI3 gene in NHEKs. Therefore we renamed it Peptidylarginine deiminase Intergenic Enhancer (PIE, EU443247 and AJ549502).
###end p 31
###begin title 32
Hypersensitivity of the CNS2 to DNase I.
###end title 32
###begin p 33
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRT</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBE</italic>
The DNase I-digestion profiles of the CNS2 including PIE, the KRT5 gene promoter region, and the two segments 114k (a LINE repeat, nt 114-549-114655) and 115k (nt 115764-115778) located at the centromeric end of IG1 are shown. The amount of template DNA was standardized by correcting for amplification of the HBE1 promoter region sequence. Inset: representative dissociation curves.
###end p 33
###begin p 34
###xml 310 318 310 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3 A</xref>
###xml 484 503 484 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3 B, lanes 1&#8211;3</xref>
###xml 1251 1259 1251 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3 C</xref>
###xml 1452 1472 1452 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3 D, grey boxes</xref>
###xml 1610 1630 1610 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3D, white boxes</xref>
###xml 1664 1668 1664 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1784 1788 1784 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Domann1">[37]</xref>
###xml 1790 1798 1790 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3 E</xref>
###xml 2091 2095 2091 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Angel1">[38]</xref>
###xml 2097 2101 2097 2101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Mehic1">[39]</xref>
###xml 2135 2139 2135 2139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 2202 2206 2202 2206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dong1">[13]</xref>
###xml 2297 2301 2297 2301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 2571 2590 2571 2590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3 B, lanes 4&#8211;7</xref>
###xml 2752 2756 2752 2756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Kardassis1">[40]</xref>
###xml 2992 2996 2992 2996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Nowak1">[41]</xref>
BLAST searches in the most recently available mammalian and nonmammalian draft genomes of the Ensembl database and the trace archives of the National Center for Biotechnology Information (NCBI), followed by sequence analysis identified one highly conserved canonical AP-1 binding sequence at each ends of PIE (Fig. 3 A). Invalidation of one or another or both AP-1 sites by site-directed mutagenesis resulted in the almost complete loss of PIE enhancer activity in luciferase assays (Fig. 3 B, lanes 1-3). Similarly, deletion of one or another or both AP-1 sites within the reporter plasmids resulted in the loss of PIE activity (not shown). In the epidermis, the AP-1 family groups heterodimeric proteins consisting of members of the Jun (c-Jun, JunB, JunD), or Fos (c-Fos, FosB, Fra1, Fra2) families, or Jun homodimers. Electrophoretic mobility shift assays (EMSA) with or without antibodies specific to each member of the Jun/Fos families was performed using nuclear extracts from differentiating NHEKs to assess wether the binding of AP-1 factors could account for the observed activity of PIE in these cells. EMSA revealed that c-Jun, c-Fos and JunB were expressed and able to bind the two AP-1 sites within PIE in differentiating keratinocytes (Fig. 3 C). Chromatin immunoprecipitation (ChIP) assays revealed a significantly increased occupancy of PIE by c-Jun and c-Fos in stimulated versus unstimulated NHEKs (2.9 and 2.8 -fold, respectively) (Fig. 3 D, grey boxes). No significant increase in occupancy by c-Jun and c-Fos was found when we queried a non related, non coding segment within IG1 (CNS3) (Fig. 3D, white boxes). Last, the effect of PIE on the PADI3 gene promoter was found impaired in stimulated NHEKs co-transfected with the c-Jun dominant negative mutant TAM67 [37] (Fig. 3 E). We concluded that c-Jun and c-Fos are recruited at PIE and that c-Jun at least is mandatory for the enhancer activity of PIE in differentiating NHEKs. This is consistent with c-Jun and c-Fos being detected in the epidermal granular layer, c-Jun being specific of this later in most reports [38], [39]. Since the basal activity of the PADI3 core promoter required binding of the factors Sp1/3 and NF-Y [13], we mutated the CCAAT or the GC-boxes, which bind NF-Y and Sp1/3 respectively, within the PADI3 promoter sequences in reporter plasmids. When inserted upstream the promoter sequence with any of the CCAAT boxes invalidated, PIE no longer showed any effect on luciferase activity. In contrast, mutations invalidating the GC boxes did not impair PIE enhancer effect (Fig. 3 B, lanes 4-7). These results suggested functional interaction of PIE with the CAAT boxes, presumably through c-Jun interacting with NF-Y as shown for the p21(WAF1/Cip1) gene [40]. We failed to detect by ChIP significant amounts of c-Jun at the promoter level (not shown). We assume this was due to the limits of ChIP when applied to proteins associated with chromatin without being directly bound to the DNA helix [41].
###end p 34
###begin title 35
AP-1 factors binding and proximal CAAT motifs required for enhancer activity.
###end title 35
###begin p 36
###xml 206 226 206 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dasypus novemcinctus</italic>
###xml 239 256 239 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Echinops telfairi</italic>
###xml 272 296 272 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ornithorhynchus anatinus</italic>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 823 827 823 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 892 896 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1085 1089 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 2722 2726 2722 2726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 3130 3134 3130 3134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 180 183 <span type="species:ncbi:10116">rat</span>
###xml 185 188 <span type="species:ncbi:9615">dog</span>
###xml 190 193 <span type="species:ncbi:9913">cow</span>
###xml 206 226 <span type="species:ncbi:9361">Dasypus novemcinctus</span>
###xml 239 256 <span type="species:ncbi:9371">Echinops telfairi</span>
###xml 262 270 <span type="species:ncbi:9258">platypus</span>
###xml 272 296 <span type="species:ncbi:9258">Ornithorhynchus anatinus</span>
A) Two conserved AP-1 sites were identified in PIE. Alignment of the sequences of the conserved telomeric or centromeric AP-1 putative binding sites (bold) in PIE in human, mouse, rat, dog, cow, armadillo (Dasypus novemcinctus), hedgehog (Echinops telfairi) and platypus (Ornithorhynchus anatinus). Sequence retrieval and analyses were performed using the Ensembl web site (), the Vista suite (), and the program Dialign-TF () with default parameters. Note that the centromeric site is more highly conserved that the telomeric site. B) AP-1 and CAAT recognition motifs are mandatory for enhancer activity. Luciferase (luc) plasmids were engineered with invalidated telomeric (AP-1t) and centromeric (AP-1c) AP-1 sites in PIE (lines 1-3), or invalidated CCAAT or GC boxes in the PADI3 promoter (cross) (lines 4-7). Line pC2-PADI3-luc: shown is the ratio between the luciferase activity of the PADI3 promoter segment with PIE versus that without PIE. Lines 1-3: shown are the ratios between the luciferase activities of the mutated constructs versus that of the construct containing the PADI3 promoter segment without PIE. Lines 4-7: shown are the ratios between the luciferase activities of the mutated constructs with PIE versus that of their counterparts without PIE. Values are expressed as means+/-SEM for 2 independent experiments, each performed in triplicate wells. C, D) Bound c-Fos/c-Jun are required for PIE function. Electrophoretic mobility shift assays (C) showed that both telomeric (AP-1t) and centromeric (AP-1c) AP-1 sites are expressed and able to bind nuclear factors from differentiating NHEKs, generating a shifted band, which is no longer detected in the presence of unlabeled wild type competitor. When antibodies specific to c-Jun, JunB or c-Fos were used, the shifted band was either supershifted or absent due to the formation of antibody-containing higher molecular weight complexes which do not enter the gel. The binding of c-Jun and c-Fos to PIE in living NHEKs was confirmed by chromatin immunoprecipitation (D). Immunoprecipitated chromatin from NHEKs grown in the presence of 1.5 mM calcium showed about 3-fold relative enrichment in c-Jun or c-Fos bound to PIE as compared to that from NHEKs grown in the presence of 0.2 mM calcium (grey bars). No enrichment was observed using antibodies to JunB or the irrelevant anti-hemaglutinin (HA), nor when we queried the unrelated CNS3 which is centromeric to the CNS2 (nt 109913-109973) (white bars). Data are shown as means+/-SEM for 2 independent experiments performed in triplicate wells. E) Blocking c-Jun or the ras/raf/ERK cascade impairs the activity of PIE. Differentiating NHEKs were co-transfected with reporter plasmids containing the PADI3 gene minimal promoter region fitted or not with PIE, and an expression vector coding for dominant negative mutants of c-Jun (TAM67), ras (ras-), raf (raf-), ERK1 and 2 (ERK1- and ERK2-, respectively) or the GFP as a control (GFP) (top). For these co-transfections, the luciferase activities generated by the plasmids containing PIE were compared with that generated by the plasmids containing only the PADI3 gene promoter. Parallel co-transfection experiments using the plasmid pAP1-luc showed dramatic loss of AP-1 activity in NHEK transfected with the dominant negative mutants (bottom). For these co-transfections, the luciferase activities generated by pAP1-luc co-tranfected with mutants were compared with that generated by pAP1-luc transfected alone. The plasmid pCR2.1 was used to adjust for the mass of the input DNA. Values are expressed as means+/-SEM for 2 independent experiments performed in triplicate wells.
###end p 36
###begin p 37
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Schmidt1">[42]</xref>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3 E</xref>
###xml 713 721 713 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3 E</xref>
AP-1 activity has been shown to be induced by the Extracellular-Regulated Kinase (ERK) signalling pathway upon keratinocyte differentiation [42]. Cotransfections of NHEKs with the PIE-PADI3 promoter reporter plasmid and any of the dominant negative mutants of ras, raf, ERK-1 or -2 all resulted in a dramatically decreased gain of the PADI3 gene promoter activity (Fig. 3 E), indicating that PIE is a downstream effector of AP-1 through the ras/raf/ERK cascade. The expression of the dominant negative mutants associated with the loss of AP-1 activity, as controlled by parallel co-transfection experiments using the plasmid pAP1-luc designed for direct monitoring of the activity of the AP-1 activation pathway (Fig. 3 E).
###end p 37
###begin p 38
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Rubtsov1">[43]</xref>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 295 301 295 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g004">Fig. 4</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dekker1">[44]</xref>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dekker2">[45]</xref>
###xml 363 370 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 529 540 529 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g004">Fig. 4, top</xref>
###xml 603 607 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 910 924 910 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g004">Fig. 4, bottom</xref>
###xml 1000 1004 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Tolhuis1">[28]</xref>
###xml 1006 1010 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Vakoc1">[46]</xref>
###xml 1064 1068 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1181 1185 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1239 1245 1236 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g004">Fig. 4</xref>
###xml 1341 1347 1338 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g004">Fig. 4</xref>
###xml 1456 1460 1453 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Recent evidence showed close proximity between long-range enhancers and promoters through chromatin loops [43]. We searched for non-random alterations in the frequency of contacts between the PADI3 gene promoter and PIE in living keratinocytes by the use of Chromosome Conformation Capture (3C, Fig. 4) [44]. Controls were included as advised elsewhere [45] (see methods). Chimeric DNA containing PIE and the PADI1 or PADI3 promoter regions were amplified using the oligonucleotide pairs BB02L/BP1R and BB02L/BP3R, respectively (Fig. 4, top). 3C allowed detection of chimeric DNA containing PIE and the PADI3 promoter region, generated by self-ligation of physically close fragments from crosslinked and restricted chromatin. More, the abundancy of such PIE-PADI3 chimeric DNA was found to be more than 20-fold greater in stimulated keratinocytes than that in unstimulated keratinocytes or dermal fibroblasts (Fig. 4, bottom), a magnitude greater than that reported for the beta globin chromatin hub [28], [46]. In contrast, the ratio between the abundancy of PIE-PADI1 chimeric DNA in unstimulated versus stimulated NHEKs was found 9-fold lower than that corresponding to PIE and PADI3 promoter, and not sensitive to calcium-stimulation (Fig. 4). No chimeric DNA could be amplified from the BAC-based control for random association events (Fig. 4), or from crude genomic DNA (not shown). This indicated non random physical association between PIE and the PADI3 gene promoter in the nuclei of differentiating NHEKs, through a chromatin looping spanning 86-kb.
###end p 38
###begin title 39
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Increased frequency of interaction between PIE and the PADI3 promoter indicating chromatin looping.
###end title 39
###begin p 40
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
The abundancy of chimeric DNA containing PIE and the promoter region of the genes PADI1 or PADI3 were explored by 3C analysis using specific primers (top). The levels of PIE-PADI3 promoter chimeric DNA in extracts from NHEKs grown in the presence of 1.5 mM calcium were approximately 20-fold greater than that in NHEKs grown in the presence of 0.2 mM calcium, or dermal fibroblasts. Amplification of BAC-based negative control for random association events (see methods) yielded no product (not shown). All amplifications were performed in triplicate wells. Results were normalized with respect to the abundancy of the PADI3 promoter sequence in the template. Data are expressed in Relative Units (RU) as means+/-SEM for 2 independent experiments, each performed in triplicate wells.*, p<0.05. Representative dissociation curves (inset) show the major amplimer peaks (arrow) along with secundary peaks (arrowhead) indicative of primer-dimer formation in some experiments. Such possible primer-dimer was not detectable in ethidium-bromide stained agarose gel of the end-point PCR reactions and did not seem to interfere with calibration curves.
###end p 40
###begin p 41
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 133 139 133 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Gonzales1">[47]</xref>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Park1">[48]</xref>
###xml 346 354 346 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Ruocco1">[49]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Park2">[50]</xref>
###xml 890 894 890 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 970 977 970 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5A</xref>
###xml 1047 1051 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1153 1160 1153 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5A</xref>
###xml 1212 1216 1212 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1221 1225 1221 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1268 1275 1268 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5A</xref>
###xml 1434 1438 1434 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Eckert2">[51]</xref>
###xml 1459 1466 1459 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5B</xref>
###xml 1908 1912 1908 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 2047 2052 2047 2052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI3</italic>
###xml 2169 2176 2169 2176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5C</xref>
###xml 2685 2692 2685 2692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5C</xref>
###xml 2931 2938 2931 2938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5C</xref>
###xml 3242 3249 3242 3249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g005">Fig. 5C</xref>
###xml 3541 3545 3541 3545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 2318 2324 <span type="species:ncbi:9986">rabbit</span>
We next queried whether the inhibition of the AP-1 pathway could have an effect upon the PADI3 mRNA levels in differentiating NHEKs (Fig. 5). We used nordihydroguaiaretic acid (NDGA), a natural polyphenolic compound reported to inhibit c-fos mRNA and protein levels, as well as binding of the fos-jun dimer to DNA in keratinocytes [47], [48] and in vitro assays [49]. It also inhibits the auto-regulated synthesis of c-jun mRNA in TPA-stimulated HL60 cells [50]. Consistently, transfection of pAP1-luc yielded no significant luciferase activity in keratinocytes treated with NDGA, in contrast to keratinocytes untreated or treated by the carrier (0.1% DMSO) (not shown). We performed real-time RT-PCR to investigate the levels of mRNA in calcium stimulated or unstimulated keratinocytes, treated or not with NDGA. For unknown reasons, 0.1% DMSO resulted in an increase of the levels of the PADI3 transcripts in unstimulated NHEKs, but had no effect in stimulated NHEKs (Fig. 5A). Whatsoever, treatment with NDGA resulted in a dramatic decrease of PADI3 mRNA levels in stimulated NHEKs, to a level close to that observed in untreated unstimulated NHEKs (Fig. 5A). We found no sensitivity to NDGA treatment of the PADI1 or PADI2 mRNA levels in calcium-stimulated NHEKs (Fig. 5A). We next queried the effect of NDGA upon the mRNA levels of a well-established AP-1 target gene, the early marker of keratinocyte differentiation involucrin [51](UniGene Hs.516439) (Fig. 5B). In untreated NHEKs, calcium stimulation resulted in a two fold increase in involucrin mRNA levels. In NHEKs treated with the carrier (DMSO), calcium stimulation associated with a five fold increase in involucrin mRNA levels. In NHEKs treated with NDGA, calcium stimulation associated with only a 1.5 fold increase in involucrin mRNA levels. Together these results suggested that treatment with NDGA blocked calcium-induced increase of the PADI3 and involucrin mRNA levels and were consistent with the assumption that targeting the AP-1 system by NDGA has a negative effect upon PADI3 expression. We next performed ChIP analysis to investigate the influence of NDGA upon PIE occupancy by c-Jun/c-Fos (Fig. 5C). We compared the number of copies of PIE present in fractions immunoprecipitated with the c-Jun antiserum or the c-Fos antiserum or a blank rabbit serum, from NHEKs grown in the presence of 0.2 mM or 1.5 mM calcium with or without NDGA. Immunoprecipitated chromatin from differentiating NHEKs grown in the presence of NDGA revealed strongly decreased occupancy of PIE by c-Jun (20% copies remaining) or c-Fos (34% copies remaining) as compared to differentiating NHEKs grown in the presence of the carrier (Fig. 5C). Immunoprecipitated chromatin from differentiating NHEKs grown in the presence of NDGA showed a much lower decrease in the non specific occupancy of PIE (74% remaining) as compared to the same cells grown in the presence of the carrier (Fig. 5C). Immunoprecipitated chromatin from NHEKs grown in the presence of 0.2 mM calcium showed no decrease in the occupancy of PIE by c-Jun (99% remaining) or c-Fos (130% remaining) or non specific factors (140% remaining) in the presence of NDGA as compared to the same cells in the presence of the carrier (Fig. 5C). These results strongly suggested that NDGA treatment is associated with a dramatic decrease in c-Jun or c-Fos recruitment at PIE. Altogether these findings supported that proper AP-1 activation system and PIE occupancy by c-Jun or c-Fos are necessary for calcium-dependent increase of the PADI3 mRNA levels.
###end p 41
###begin title 42
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
NDGA blocks calcium-induced increase of the PADI3 mRNA levels and impairs c-Jun or c-Fos recruitment at PIE.
###end title 42
###begin p 43
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 449 453 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 472 476 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 529 533 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 549 564 542 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;&#916;&#916;Ct)</sup>
###xml 660 664 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1217 1221 1198 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Quantitative RT-PCR analysis of the steady-state levels of PADI1-3 (A) and involucrin (B) mRNAs was performed using unstimulated or calcium-stimulated NHEKs grown in the presence of 20 microM NDGA in 0.1% DMSO, or 0.1% DMSO, and the beta2-microglobulin mRNA as the reference. Data are expressed as means+/-SEM for 2 independent experiments, each performed in triplicate wells.*, p<0.05. A) NDGA blocks calcium-induced increase of the mRNA levels of PADI3, but not that of PADI 1, 2. Treatment with 0.1% DMSO had no effect on the PADI3 mRNA levels (2(-DeltaDeltaCt)) in calcium-stimulated NHEKs. Treatment with 20 microM NDGA resulted in a dramatic decrease of PADI3 mRNA levels in calcium-stimulated NHEKs. B) NDGA blocks calcium-induced increase of the involucrin mRNA levels. In untreated NHEKs, calcium stimulation resulted in a two fold increase in involucrin mRNA levels. In NHEKs treated with the carrier (DMSO), calcium stimulation associated with a five fold increase in involucrin mRNA levels. In NHEKs treated with NDGA, calcium stimulation associated with only a 1.5 fold increase in involucrin mRNA levels. Together these results suggested that treatment with NDGA blocked calcium-induced increase of the PADI3 and involucrin mRNA levels. RU, relative units. C) NDGA impairs c-Jun or c-Fos recruitment at PIE in calcium-stimulated NHEKs. ChIP analysis of PIE occupancy by c-Jun/c-Fos was performed in the presence of NDGA or the carrier (DMSO). Immunoprecipitated chromatin from NHEKs grown in the presence of 1.5 mM calcium showed strongly decreased occupancy of PIE by c-Jun (20% remaining) or c-Fos (34% remaining) but not non specific factors (74% remaining) in the presence of NDGA as compared to the same cells grown in the presence of the carrier. Immunoprecipitated chromatin from NHEKs grown in the presence of 0.2 mM calcium showed no decrease in the occupancy of PIE by c-Jun (99% remaining) or c-Fos (130% remaining) or non specific factors (140% remaining) in the presence of NDGA as compared to NHEKs grown in the presence of the carrier. Data are expressed as Relative Units (RU) and shown as means+/-SEM for 2 independent experiments performed in triplicate wells. *, p<0.05.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 268 274 268 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g006">Fig. 6</xref>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 440 448 440 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 483 487 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 591 595 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Our findings show that a distal enhancer located 86-kb telomeric to the gene PADI3, namely PIE, underlies efficient transcription of this gene in calcium differentiated epidermal keratinocytes through binding to AP-1 factors and in association with chromatin looping (Fig. 6). To our knowledge, PIE exhibits all requirements for an enhancer: its sequence is highly conserved in mammals, it exerts a strong effect on the PADI3 gene promoter in vitro, and, in conditions when the gene PADI3 is specifically upregulated, it is DNase I hypersensitive, shows non random physical proximity to the PADI3 gene promoter, and binds transcription activators (AP-1). We found that the AP-1 inhibitor NDGA suppresses the calcium-induced increase of PADI3 mRNA levels in keratinocytes, and the occupancy of PIE by c-Jun and c-Fos. However, possible non-specific cellular effects of NDGA can not be ruled out. Targeting experiments with silencing RNAs specific to c-Jun and/or c-Fos would help to adress this issue.
###end p 45
###begin title 46
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Possible model for PADI3 promoter regulation.
###end title 46
###begin p 47
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
The binding of cJun and/or cFos dimers to the AP-1 sites of PIE is enhanced in calcium-stimulated keratinocytes and increases the rate of transcription of PADI3 (broken arrow). Transcription factors with functional association (cJun, cFos, NF-Y) are shown as open circles. Sp1/3 factors are denoted as grey circles. Transcription factors binding sites are indicated (capital letters). The arrows show the transcription orientation of the genes PADI1-2 (white boxes). TBP: TATA-box binding protein; pol II: RNA polymerase II.
###end p 47
###begin p 48
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Germain1">[52]</xref>
###xml 215 219 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Virolle1">[26]</xref>
###xml 254 258 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Yamaguchi1">[53]</xref>
###xml 407 411 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Kardassis2">[54]</xref>
###xml 412 416 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Blaine1">[56]</xref>
###xml 610 614 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Ransone1">[57]</xref>
###xml 51 55 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 188 193 <span type="species:ncbi:10090">mouse</span>
###xml 228 233 <span type="species:ncbi:9940">sheep</span>
###xml 357 361 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
We observed an effect of PIE upon the heterologous SV40 promoter, such as observed with a variety of other AP-1 bound distal enhancers as those for the human renin gene promoter [52], the mouse laminin alpha3A gene [26], or the sheep interferon tau gene [53]. It is likely due to the positive interaction between c-Jun and the factor Sp1 which binds to the SV40 promoter, as observed in a number of studies [54]-[56]. Direct interaction with the viral TATA-box throught the TATA-box binding protein (TBP) is also a possible mecanism, given the ability of c-Fos and c-Jun proteins to interact directly with TBP [57].
###end p 48
###begin p 49
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 199 202 199 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Chavanas1">[3]</xref>
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003408-g003">Fig. 3A</xref>
###xml 515 519 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 278 286 <span type="species:ncbi:9258">platypus</span>
Because PIE is located within the PADI1-2 intergenic region, it supports the assumption that the use of distant cis-regulatory elements contributes to maintain the physical organization of the locus [3]. We retrieved ortholog PIE sequences from placental mammals and monotreme (platypus) (Fig. 3A), but not from nonmammalian vertebrates, what suggests that PIE is a mammalian novelty. The role of the other CNS in IG1, should they have any, is unknown. It is possible that they exert a function respective to other PADI genes, cell types, or stimuli than the ones we queried. We recently identified another calcium-responsive enhancer activity lying within a large restriction fragment of IG1 (VA, unpublished data), presumably arising from the possible co-operation between two or more CNS with no detectable activity when assayed individually, or from a subsequence that had not been listed as a CNS because of a lower degree of conservation.
###end p 49
###begin p 50
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Shaulian1">[58]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Jang1">[59]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Rossi1">[60]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Eferl1">[61]</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Neub1">[62]</xref>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Shaulian1">[58]</xref>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Chen1">[63]</xref>
AP-1 factors are key regulators of cell life and death through the control of gene transcription in response to extracellular stimuli such as growth factors or cytokines [58]. Specifically, c-Jun/c-Fos heterodimers have been reported to be activators of the transcription of the genes encoding profilaggrin [59], loricrin, involucrin and transglutaminase 1 [60], all critical components of the terminally differentiated keratinocyte. Also, our results pave the way to the exploration of deimination control during tumorigenesis and wound healing, two conditions for which AP-1 factors are critical [61], [62]. Our results reveal that the ras/raf/ERK cascade is required for PIE activity during calcium-mediated NHEK differentiation. However, AP-1 factors can also be activated by the JNK/P38 kinase pathway upon stimulation by pro-inflammatory cytokines or genotoxic stress [58], and AP-1 transactivation is a key downstream events that results from UVB irradiation in keratinocytes [63]. Whether the JNK/P38 pathway has a role on PIE activity remains to be addressed, and would be of interest with respect to the molecular responses of epidermal keratinocytes to genotoxic stress.
###end p 50
###begin p 51
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 579 582 579 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Kleinjan1">[2]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Dekker1">[44]</xref>
###xml 735 738 735 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Kleinjan1">[2]</xref>
###xml 931 935 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Vilar1">[64]</xref>
###xml 972 976 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 1073 1075 1073 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 1182 1186 1182 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Sim1">[65]</xref>
###xml 1257 1261 1257 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPRR</italic>
###xml 1414 1422 1414 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1427 1434 1427 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1434 1438 1434 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Martin1">[66]</xref>
###xml 1568 1572 1568 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Antonini1">[67]</xref>
This is the first time distant regulation of a PADI gene is reported. We observed local chromatin opening and chromatin looping in conditions when PIE-bound AP-1 factors trigger transcription of the gene PADI3. Though we can not rule out that these events are simply correlative, together our findings strongly support that the increased proximity between PIE and the PADI3 gene promoter through chromatin bending is at least a major contribution in PADI3 enhanced transcription. This is consistent with the model that chromatin plasticity is a key feature for genome expression [2], [44]. Long-range enhancers have been identified in a variety of chromosomal regions and tissues, at a distance up to 1-Mb from their cognate promoters [2]. Chromatin loops have been reported to play a role in the cell specificity of gene expression, in the control of transcriptional noise level, and in the activation of cooperative interactions [64]. PIE is located 86-kb away from the PADI3 gene promoter on chromosome 1p36. It has been proposed that the Wilms' tumour suppressor gene, WT1, also located on 1p35-36, is regulated by an enhancer away from more than 9-kb of its 5' proximal region [65]. The identification of a distant transcriptional enhancer of the gene SPRR1A within the 5-Mb epidermal differentiation complex (EDC) on 1q21 was an important finding to understand the control of its expression in keratinocytes in vitro and in vivo[66]. More, the transcription of the p63 gene is regulated by a keratinocyte-specific enhancer located 160-kb away on chromosome 3q28 [67]. Together with these studies, our findings support that transcriptional regulation at a distance might be a key issue in keratinocyte biology.
###end p 51
###begin p 52
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 381 388 381 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 511 514 511 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003408-Kleinjan1">[2]</xref>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 327 332 <span type="species:ncbi:10090">mouse</span>
###xml 495 500 <span type="species:ncbi:9606">human</span>
In conclusion, the genetic bases of the distinctive patterns of expression of the genes PADI are unclear, despite the characterization of their respective core promoters. We assume that long range control of transcription, involving IG1 or introns, should have a role in the regulation of deimination. A forthcoming transgenic mouse model will definitely elucidate the role of PIE in vivo, in normal or pathological conditions. The impairment of long range control underlies a variety of severe human disorders [2]. Therefore PIE and other CNS within IG1 can be reasonably considered as candidates in association studies for deimination-related disorders or atopic disease, and we have included them in a recently initiated screen of the PADI locus in the search for variant haplotypes possibly associated with rheumatoid arthritis.
###end p 52
###begin title 53
Supporting Information
###end title 53
###begin p 54
Oligonucleotide probes used in this study
###end p 54
###begin p 55
(0.07 MB DOC)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
3C detailed protocol for NHEKs
###end p 57
###begin p 58
(0.03 MB DOC)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
We are indebted to C. Bouissou-Bouchouata for expert assistance, C. Offer and H. Brun for sequencing, M. Cobb, M. Karin, M. Birrer and F. Verrechia for providing plasmids, N. Fusening for the gift of HaCaT cells and to P. Gallinie and J.-P. Chavoin for providing with skin samples.
###end p 60
###begin title 61
References
###end title 61
###begin article-title 62
###xml 64 69 <span type="species:ncbi:9606">human</span>
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.
###end article-title 62
###begin article-title 63
Long-range control of gene expression: emerging mechanisms and disruption in disease.
###end article-title 63
###begin article-title 64
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6.
###end article-title 64
###begin article-title 65
Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells.
###end article-title 65
###begin article-title 66
Histone deimination antagonizes arginine methylation.
###end article-title 66
###begin article-title 67
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human PAD4 regulates histone arginine methylation levels via demethylimination.
###end article-title 67
###begin article-title 68
Peptidylarginine deiminases and deimination in biology and pathology: Relevance to skin homeostasis.
###end article-title 68
###begin article-title 69
###xml 92 97 <span type="species:ncbi:9606">Human</span>
Preferential Deimination of Keratin K1 and Filaggrin during the Terminal Differentiation of Human Epidermis.
###end article-title 69
###begin article-title 70
Moisturization and skin barrier function.
###end article-title 70
###begin article-title 71
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.
###end article-title 71
###begin article-title 72
Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin.
###end article-title 72
###begin article-title 73
###xml 45 50 <span type="species:ncbi:9606">human</span>
The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations.
###end article-title 73
###begin article-title 74
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 123 128 <span type="species:ncbi:9606">human</span>
NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.
###end article-title 74
###begin article-title 75
###xml 34 39 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of the human cystathionine beta-synthase -1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3.
###end article-title 75
###begin article-title 76
Functional Interaction of NF-Y and Sp1 Is Required for Type A Natriuretic Peptide Receptor Gene Transcription.
###end article-title 76
###begin article-title 77
###xml 86 89 <span type="species:ncbi:10116">Rat</span>
Sp Family Members and Nuclear Factor-Y Cooperatively Stimulate Transcription from the Rat Pyruvate Kinase M Gene Distal Promoter Region via Their Direct Interactions.
###end article-title 77
###begin article-title 78
###xml 76 81 <span type="species:ncbi:9606">human</span>
Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene.
###end article-title 78
###begin article-title 79
Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: Potential roles for Sp1/Sp3, NF-Y, and p63.
###end article-title 79
###begin article-title 80
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
###end article-title 80
###begin article-title 81
Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
###end article-title 81
###begin article-title 82
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 83 88 <span type="species:ncbi:9606">human</span>
Regulation of the expression of peptidylarginine deiminase type II gene (PADI2) in human keratinocytes involves Sp1 and Sp3 transcription factors.
###end article-title 82
###begin article-title 83
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
###xml 121 126 <span type="species:ncbi:9606">Human</span>
Crucial Roles of MZF1 and Sp1 in the Transcriptional Regulation of the Peptidylarginine Deiminase Type I Gene (PADI1) in Human Keratinocytes.
###end article-title 83
###begin article-title 84
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI</italic>
Estrogen-Enhanced Peptidylarginine Deiminase Type IV Gene (PADI4) Expression in MCF-7 Cells Is Mediated by Estrogen Receptor-{alpha}-Promoted Transfactors Activator Protein-1, Nuclear Factor-Y, and Sp1.
###end article-title 84
###begin article-title 85
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Quantification of DNaseI-sensitivity by real-time PCR: quantitative analysis of DNaseI-hypersensitivity of the mouse beta-globin LCR.
###end article-title 85
###begin article-title 86
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
###end article-title 86
###begin article-title 87
###xml 104 110 <span type="species:ncbi:10090">murine</span>
Three activator protein-1-binding sites bound by the Fra-2.JunD complex cooperate for the regulation of murine laminin alpha3A (lama3A) promoter activity by transforming growth factor-beta.
###end article-title 87
###begin article-title 88
Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity.
###end article-title 88
###begin article-title 89
Looping and interaction between hypersensitive sites in the active beta-globin locus.
###end article-title 89
###begin article-title 90
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DeltaDelta C(T)) Method.
###end article-title 90
###begin article-title 91
###xml 44 49 <span type="species:ncbi:9606">human</span>
Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture.
###end article-title 91
###begin article-title 92
The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation.
###end article-title 92
###begin article-title 93
###xml 79 84 <span type="species:ncbi:9606">human</span>
A novel protease inhibitor of the alpha2-macroglobulin family expressed in the human epidermis.
###end article-title 93
###begin article-title 94
Expression of GATA-1 in a Non-hematopoietic Cell Line Induces [beta]-Globin Locus Control Region Chromatin Structure Remodeling and an Erythroid Pattern of Gene Expression.
###end article-title 94
###begin article-title 95
###xml 49 54 <span type="species:ncbi:9606">human</span>
Syndecan-2 and -4 expressed on activated primary human CD4+ lymphocytes can regulate T cell activation.
###end article-title 95
###begin article-title 96
High-Resolution Mapping and Characterization of Open Chromatin across the Genome.
###end article-title 96
###begin article-title 97
Interferon Regulatory Factors Are Transcriptional Regulators of Adipogenesis.
###end article-title 97
###begin article-title 98
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 115 124 <span type="species:ncbi:10090">nude mice</span>
Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice.
###end article-title 98
###begin article-title 99
Function and regulation of AP-1 subunits in skin physiology and pathology.
###end article-title 99
###begin article-title 100
###xml 74 79 <span type="species:ncbi:9606">Human</span>
Fos and Jun Proteins Are Specifically Expressed During Differentiation of Human Keratinocytes.
###end article-title 100
###begin article-title 101
###xml 41 46 <span type="species:ncbi:9606">human</span>
c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1.
###end article-title 101
###begin article-title 102
Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation.
###end article-title 102
###begin article-title 103
Ras-independent activation of the Raf/MEK/ERK pathway upon calcium-induced differentiation of keratinocytes.
###end article-title 103
###begin article-title 104
Chromatin structure can strongly facilitate enhancer action over a distance.
###end article-title 104
###begin article-title 105
Capturing chromosome conformation.
###end article-title 105
###begin article-title 106
The three 'C' s of chromosome conformation capture: controls, controls, controls.
###end article-title 106
###begin article-title 107
Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1.
###end article-title 107
###begin article-title 108
###xml 105 110 <span type="species:ncbi:9606">human</span>
Nordihydroguaiaretic acid-mediated inhibition of ultraviolet B-induced activator protein-1 activation in human keratinocytes.
###end article-title 108
###begin article-title 109
Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells.
###end article-title 109
###begin article-title 110
A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1.
###end article-title 110
###begin article-title 111
Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
###end article-title 111
###begin article-title 112
Regulation of involucrin gene expression.
###end article-title 112
###begin article-title 113
###xml 60 65 <span type="species:ncbi:9606">Human</span>
A Novel Distal Enhancer Confers Chorionic Expression on the Human Renin Gene.
###end article-title 113
###begin article-title 114
###xml 71 76 <span type="species:ncbi:9940">sheep</span>
Identification of a functional transcriptional factor AP-1 site in the sheep interferon tau gene that mediates a response to PMA in JEG3 cells.
###end article-title 114
###begin article-title 115
###xml 41 46 <span type="species:ncbi:9606">Human</span>
c-Jun Transactivates the Promoter of the Human p21WAF1/Cip1 Gene by Acting as a Superactivator of the Ubiquitous Transcription Factor Sp1.
###end article-title 115
###begin article-title 116
Induction of Disease-associated Keratin 16 Gene Expression by Epidermal Growth Factor Is Regulated through Cooperation of Transcription Factors Sp1 and c-Jun.
###end article-title 116
###begin article-title 117
Induction of cPLA2 in Lung Epithelial Cells and Non-small Cell Lung Cancer Is Mediated by Sp1 and c-Jun.
###end article-title 117
###begin article-title 118
The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.
###end article-title 118
###begin article-title 119
AP-1 as a regulator of cell life and death.
###end article-title 119
###begin article-title 120
###xml 129 134 <span type="species:ncbi:9606">Human</span>
Activator Protein 1Activity Is Involved in the Regulation of the Cell Type-specific Expression from the Proximal Promoter of the Human Profilaggrin Gene.
###end article-title 120
###begin article-title 121
###xml 81 86 <span type="species:ncbi:9606">Human</span>
Effect of AP1 Transcription Factors on the Regulation of Transcription in Normal Human Epidermal Keratinocytes.
###end article-title 121
###begin article-title 122
AP-1: a double-edged sword in tumorigenesis.
###end article-title 122
###begin article-title 123
###xml 44 49 <span type="species:ncbi:9606">Human</span>
Biphasic Regulation of AP-1 Subunits during Human Epidermal Wound Healing.
###end article-title 123
###begin article-title 124
###xml 108 113 <span type="species:ncbi:9606">Human</span>
UVB Irradiation-induced Activator Protein-1 Activation Correlates with Increased c-fos Gene Expression in a Human Keratinocyte Cell Line.
###end article-title 124
###begin article-title 125
DNA looping in gene regulation: from the assembly of macromolecular complexes to the control of transcriptional noise.
###end article-title 125
###begin article-title 126
Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
###end article-title 126
###begin article-title 127
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation.
###end article-title 127
###begin article-title 128
An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer.
###end article-title 128
###begin p 129
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 129
###begin p 130
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Paul Sabatier University (UPS), Centre National de la Recherche Scientifique (CNRS), European Social Fund (ESF), European Regional Development Fund (ERDF) and Pierre-Fabre Research Institute (CERPER, Toulouse).
###end p 130

